Life Sciences Times, Author at Life Sciences Times

Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Expanding Clinical Data Capabilities to Accelerate Drug Development

October 29, 2025

Boston IVF Chief Scientific Officer Denny Sakkas, PhD Receives Prestigious 2025 ASRM Distinguished Researcher Award for Lifetime Contributions to Fertility Research

October 27, 2025

Alloy Therapeutics Announces Acquisition of Spannerwerks, a Leading Provider of Drug Development Consulting Services

October 23, 2025

THIS WEEK'S STORIES

Corsera Health Files First Phase 1 Clinical Trial Application for Preventive RNAi Medicine Targeting Cardiovascular Disease

October 27, 2025

Hovione Completes $100 Million Expansion to Grow U.S. Manufacturing Operations in New Jersey

October 27, 2025

Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration

October 28, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences Times

TOP AUTHORS

Most Read

InterVene Receives FDA Clearance for Recana, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions

Manhattan Genomics Assembles World-Class Scientific Team to Lead a New Era of Genomic Medicine

Gut Neurons Decoded: New Study Reveals How Food Allergies and Microbes Rewire the Gut’s Nervous System

Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis

EDITOR PICKS

Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Expanding Clinical Data Capabilities to Accelerate Drug Development

Boston IVF Chief Scientific Officer Denny Sakkas, PhD Receives Prestigious 2025 ASRM Distinguished Researcher Award for Lifetime Contributions to Fertility Research

Alloy Therapeutics Announces Acquisition of Spannerwerks, a Leading Provider of Drug Development Consulting Services

THIS WEEK'S STORIES

Corsera Health Files First Phase 1 Clinical Trial Application for Preventive RNAi Medicine Targeting Cardiovascular Disease

Hovione Completes $100 Million Expansion to Grow U.S. Manufacturing Operations in New Jersey

Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration

POPULAR CATEGORY

ABOUT US

FOLLOW US